Romiplostim as a treatment for immune thrombocytopenia: a review
Sarah Chalmers,1,2 Michael D Tarantino1–31University of Illinois College of Medicine – Peoria, 2The Children's Hospital of Illinois, 3The Bleeding and Clotting Disorders Institute, Peoria, Illinois, USAAbstract: “Immune thrombocytopenia” (ITP) is an au...
Main Authors: | Chalmers S, Tarantino MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-01-01
|
Series: | Journal of Blood Medicine |
Online Access: | http://www.dovepress.com/romiplostim-as-a-treatment-for-immune-thrombocytopenia-a-review-peer-reviewed-article-JBM |
Similar Items
-
Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
by: Francesca Palandri, et al.
Published: (2012-06-01) -
Safety and efficacy of romiplostim in children and adolescents with Immune thrombocytopenia: A systematic review
by: Fernanda Lubiana de Oliveira, et al.
Published: (2023-01-01) -
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
by: D. J. Kuter, et al.
Published: (2015-01-01) -
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
by: D. J. Kuter, et al.
Published: (2015-01-01) -
Total remission of severe immune thrombocytopenia after short term treatment with romiplostim
by: Efthymia Vlachaki, et al.
Published: (2011-10-01)